Potential of ginsenoside Rh2and its derivatives as anti-cancer agents

Chin J Nat Med. 2022 Dec;20(12):881-901. doi: 10.1016/S1875-5364(22)60193-6.

Abstract

As a steroid skeleton-based saponin, ginsenoside Rh2 (G-Rh2) is one of the major bioactive ginsenosides from the plants of genus Panax L. Many studies have reported the notable pharmacological activities of G-Rh2 such as anticancer, antiinflammatory, antiviral, antiallergic, antidiabetic, and anti-Alzheimer's activities. Numerous preclinical studies have demonstrated the great potential of G-Rh2 in the treatment of a wide range of carcinomatous diseases in vitro and in vivo. G-Rh2 is able to inhibit proliferation, induce apoptosis and cell cycle arrest, retard metastasis, promote differentiation, enhance chemotherapy and reverse multi-drug resistance against multiple tumor cells. The present review mainly summarizes the anticancer effects and related mechanisms of G-Rh2 in various models as well as the recent advances in G-Rh2 delivery systems and structural modification to ameliorate its anticancer activity and pharmacokinetics characteristics.

Keywords: Anticancer; Drug delivery systems; Ginsenoside Rh(2); Mechanisms of action; Synergistic effect.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Apoptosis
  • Ginsenosides* / pharmacology
  • Humans
  • Neoplasms* / drug therapy
  • Saponins* / pharmacology

Substances

  • Ginsenosides
  • Antineoplastic Agents
  • Saponins